Cosciens Biopharma Inc (CSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 11-1993 | 08-1993 | 05-1993 | 02-1993 | 11-1992 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 4,594 | 4,594 | 6,232 | 7,629 | 7,641 |
| TOTAL | $4,594 | $4,594 | $6,232 | $7,629 | $7,641 |
| Non-Current Assets | |||||
| PPE Net | 1,687 | 1,687 | 1,489 | 1,576 | 1,685 |
| Other Non-Current Assets | 6,926 | 6,926 | 7,411 | 7,043 | 6,673 |
| TOTAL | $8,613 | $8,613 | $8,900 | $8,619 | $8,358 |
| Total Assets | $13,207 | $13,207 | $15,132 | $16,248 | $15,999 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,575 | 2,575 | 1,000 | 752 | 881 |
| Accounts payable and accrued liabilities | 1,256 | 1,256 | 1,144 | 1,592 | 1,490 |
| Accrued Expenses | 806 | 806 | 388 | 350 | 411 |
| Other current liabilities | 325 | 325 | 1 | 0 | 1 |
| TOTAL | $4,962 | $4,962 | $2,533 | $2,694 | $2,529 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $4 | $4 | $4 |
| Total Liabilities | $4,962 | $4,962 | $2,537 | $2,698 | $2,533 |
| Shareholders' Equity | |||||
| Common Shares | 53 | 53 | 53 | 53 | 53 |
| Other shareholders' equity | 55 | 55 | 55 | 0 | 0 |
| TOTAL | $9,577 | $9,577 | $9,557 | $9,502 | $9,502 |
| Total Liabilities And Equity | $14,539 | $14,539 | $12,094 | $12,200 | $12,035 |